The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | 9,159 | 650,000 | SH | SOLE | 650,000 | 0 | 0 | ||
| ALX ONCOLOGY HLDGS INC | COM | 00166B105 | 25,373 | 3,136,352 | SH | SOLE | 3,136,352 | 0 | 0 | ||
| APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 67,830 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | ||
| ARCUTIS BIOTHERAPEUTICS INC | COM | 03969K108 | 21,310 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| ATHIRA PHARMA INC | COM | 04746L104 | 671 | 220,000 | SH | SOLE | 220,000 | 0 | 0 | ||
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | 088786108 | 28,526 | 1,700,000 | SH | SOLE | 1,700,000 | 0 | 0 | ||
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | 152309100 | 1,947 | 399,801 | SH | SOLE | 399,801 | 0 | 0 | ||
| CENTURY THERAPEUTICS INC | COM | 15673T100 | 4,003 | 476,559 | SH | SOLE | 476,559 | 0 | 0 | ||
| CHEMOCENTRYX INC | COM | 16383L106 | 14,868 | 600,000 | SH | SOLE | 600,000 | 0 | 0 | ||
| CYTOKINETICS INC | COM NEW | 23282W605 | 68,758 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| DESIGN THERAPEUTICS INC | COM | 25056L103 | 39,165 | 2,797,501 | SH | SOLE | 2,797,501 | 0 | 0 | ||
| DICE THERAPEUTICS INC | COM | 23345J104 | 15,291 | 985,251 | SH | SOLE | 985,251 | 0 | 0 | ||
| DYNE THERAPEUTICS INC | COM | 26818M108 | 19,923 | 2,900,000 | SH | SOLE | 2,900,000 | 0 | 0 | ||
| EDGEWISE THERAPEUTICS INC | COM | 28036F105 | 1,194 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| FULCRUM THERAPEUTICS INC | COM | 359616109 | 9,555 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| HORIZON THERAPEUTICS PUB L | SHS | G46188101 | 27,916 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | ||
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | 51,750 | 3,750,000 | SH | SOLE | 3,750,000 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 1,708 | 369,800 | SH | SOLE | 369,800 | 0 | 0 | ||
| KARUNA THERAPEUTICS INC | COM | 48576A100 | 18,977 | 150,000 | SH | SOLE | 150,000 | 0 | 0 | ||
| KEZAR LIFE SCIENCES INC | COM | 49372L100 | 7,857 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | ||
| LIANBIO | SPONSORED ADS | 53000N108 | 852 | 394,486 | SH | SOLE | 394,486 | 0 | 0 | ||
| NEUROCRINE BIOSCIENCES INC | COM | 64125C109 | 29,244 | 300,000 | SH | SOLE | 300,000 | 0 | 0 | ||
| NUVALENT INC | COM | 670703107 | 460 | 33,887 | SH | SOLE | 33,887 | 0 | 0 | ||
| NUVATION BIO INC | *W EXP 07/07/202 | 67080N119 | 19 | 66,666 | SH | SOLE | 66,666 | 0 | 0 | ||
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | 15,238 | 3,743,875 | SH | SOLE | 3,743,875 | 0 | 0 | ||
| PYXIS ONCOLOGY INC | COMMON STOCK | 747324101 | 525 | 220,434 | SH | SOLE | 220,434 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | COM | 803607100 | 29,984 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| SPRUCE BIOSCIENCES INC | COM | 85209E109 | 1,740 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TALARIS THERAPEUTICS INC | COM | 87410C104 | 1,222 | 270,987 | SH | SOLE | 270,987 | 0 | 0 | ||
| TYRA BIOSCIENCES INC | COM | 90240B106 | 1,191 | 166,526 | SH | SOLE | 166,526 | 0 | 0 | ||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 28,284 | 2,312,680 | SH | SOLE | 2,312,680 | 0 | 0 | ||
| VIGIL NEUROSCIENCE INC | COM | 92673K108 | 530 | 205,595 | SH | SOLE | 205,595 | 0 | 0 | ||